Literature DB >> 21984112

cis-9,trans-11,cis-15 and cis-9,trans-13,cis-15 CLNA mixture activates PPARα in HEK293 and reduces triacylglycerols in 3T3-L1 cells.

Jonatan Miranda1, Arrate Lasa, Alfredo Fernández-Quintela, Cristina García-Marzo, Josune Ayo, Renaud Dentin, María P Portillo.   

Abstract

Scientific research is constantly working to find new molecules that are effective in preventing excessive accumulation of body fat. The aim of the present work was to assess the potential agonism on PPARα and PPARγ of a conjugated linolenic acid (CLNA) isomer mixture, consisting of two CLNA isomers (cis-9,trans-11,cis-15 and cis-9,trans-13,cis-15). Secondly, we aimed to analyze the effects of this mixture on triacylglycerol accumulation in 3T3-L1 mature adipocytes. Luciferase transactivation assay was used to analyze whether the CLNA mixture activated PPARs. The expression of several enzymes and transcriptional factors involved in the main metabolic pathways that control triacylglycerol accumulation in adipocytes was assessed by real time RT-PCR in 3T3-L1 adipocytes treated for 20 h with the CLNA mixture. The mixture activated PPRE in cells with PPARα receptor over-expression, but not those with PPARγ over-expression. Decreased triacylglycerol was found in treated adipocytes. The lowest dose (10 μM) increased HSL expression and the highest dose (100 μM) increased ATGL gene expression. The other genes analyzed remained unchanged. The hypothesis of an anti-obesity action of the analyzed CLNA mixture, based on increased lipid mobilization in adipose tissue, can be proposed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984112     DOI: 10.1007/s11745-011-3615-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Conjugated linoleic acids: all the same or to everyone its own function?

Authors:  Jean-Charles Martin; Karine Valeille
Journal:  Reprod Nutr Dev       Date:  2002 Nov-Dec

Review 3.  Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.

Authors:  N Latruffe; J Vamecq
Journal:  Biochimie       Date:  1997 Feb-Mar       Impact factor: 4.079

4.  Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha.

Authors:  S Y Moya-Camarena; J P Vanden Heuvel; S G Blanchard; L A Leesnitzer; M A Belury
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

Review 5.  Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism.

Authors:  J Salas-Salvadó; F Márquez-Sandoval; M Bulló
Journal:  Crit Rev Food Sci Nutr       Date:  2006       Impact factor: 11.176

6.  Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans.

Authors:  Leah D Whigham; Abigail C Watras; Dale A Schoeller
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

7.  Comparative study between the effect of the peroxisome proliferator activated receptor-alpha ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5'-AMP-activated protein kinase-alpha1 in high-fat fed rats.

Authors:  Tarek M Kamal Motawi; Reem M Hashem; Laila A Rashed; Sabry M Abd El-Razek
Journal:  J Pharm Pharmacol       Date:  2009-10       Impact factor: 3.765

8.  Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue.

Authors:  Raquel Hontecillas; Maggie Diguardo; Elisa Duran; Marcel Orpi; Josep Bassaganya-Riera
Journal:  Clin Nutr       Date:  2008-09-07       Impact factor: 7.324

9.  Effect of conjugated FA on feed intake, body composition, and liver FA in mice.

Authors:  J M Chardigny; O Hasselwander; M Genty; K Kraemer; A Ptock; J L Sébédio
Journal:  Lipids       Date:  2003-09       Impact factor: 1.880

10.  Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists.

Authors:  Josep Bassaganya-Riera; Amir J Guri; Raquel Hontecillas
Journal:  J Obes       Date:  2010-12-28
View more
  5 in total

1.  Pomegranate Oil's Potential as an Anti-Obesity Ingredient.

Authors:  Manuela Machado; Eduardo M Costa; Sara Silva; Luís M Rodriguez-Alcalá; Ana M Gomes; Manuela Pintado
Journal:  Molecules       Date:  2022-08-04       Impact factor: 4.927

2.  Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet.

Authors:  Xiaopo Zhang; Chongming Wu; Haifeng Wu; Linghui Sheng; Yan Su; Xue Zhang; Hong Luan; Guibo Sun; Xiaobo Sun; Yu Tian; Yubin Ji; Peng Guo; Xudong Xu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

3.  Role of the lower and upper intestine in the production and absorption of gut microbiota-derived PUFA metabolites.

Authors:  Céline Druart; Audrey M Neyrinck; Bruno Vlaeminck; Veerle Fievez; Patrice D Cani; Nathalie M Delzenne
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

4.  The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components.

Authors:  Gou-Chun Chen; Wen-Hung Chen; Kuo-Tang Tseng; Pei-Min Chao
Journal:  Lipids Health Dis       Date:  2017-09-29       Impact factor: 3.876

5.  Effect of Pufa Substrates on Fatty Acid Profile of Bifidobacterium breve Ncimb 702258 and CLA/CLNA Production in Commercial Semi-Skimmed Milk.

Authors:  Ana Luiza Fontes; Lígia Pimentel; Luis Miguel Rodríguez-Alcalá; Ana Gomes
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.